Pharmacy Report Archives - Page 44 of 154 - Becker's Hospital Review

Senate bill offers 340B protection | FDA: AbbVie ad misleading | 10 systems seeking pharmacy leaders | The PTO problem for execs | Are GLP-1 shortages easing? | Yale settles drug tampering lawsuit

September 12, 2024 BHR Newsletter 1. New Senate bill to protect 340B program Full story 2. 93 women, Yale, settle lawsuit over replaced painkillers Full story 3. Novo Nordisk pill reduces body weight by 13% in 3 months Full story…

How Ochsner empowers pharmacists | Lung cancer drug fails phase 3 trial | Top recommended hospitals | Optum drops Humira | Pros, cons of 'microretirement'

September 11, 2024 BHR Newsletter 1. AstraZeneca lung cancer drug fails trial Full story 2. FDA targets production limits in plan to ease ADHD drug shortage Full story 3. Inside Ochsner's pharmacogenomic testing program Full story 4. How Intermountain +…

AbbVie sues rival | Gene therapy sees early success | PBMs by market share | Payer CEO: Expect 'choppiness' in GLP-1 coverage | ASHP backs Mo. 340B expansion

September 10, 2024 BHR Newsletter 1. AbbVie sues BeiGene over alleged trade secret theft Full story 2. AMA pushes for scrutiny of PBM market consolidation Full story 3. Gene therapy shows promise in early childhood blindness Full story 4. Learn…

Drugmaker could reach $1 trillion valuation | Alleged med error hospitalizes 3 children | New uses for arthritis drugs | Md. judge upholds 340B law | COVID shot rollout delayed

September 9, 2024 BHR Newsletter 1. Drugmaker might be 1st healthcare company to top $1 trillion valuation Full story 2. Arthritis medications could help heal COVID-19 lung damage: Study Full story 3. Judge rules against drugmakers in Maryland 340B law…

Lawsuit: Walgreens cold med contains benzene | Glucose monitors go OTC | 10 systems seeking pharmacy leaders | Top schools for 1st-time NAPLEX pass rates | 350 cleanest hospitals

September 5, 2024 BHR Newsletter 1. Walgreens sued over alleged carcinogenic cold medicine Full story 2. 1st OTC continuous glucose monitor enters US market Full story 3. 'Perfect storm for cash flow': How this hospital missed payroll Full story 4.…

6 new drug shortages | Pharmacies not ready for DSCSA | Revolutionizing patient care | Ozempic generic to launch in 2030 | AMA urged to drop 'scope creep' effort

September 4, 2024 BHR Newsletter 1. Pharmacies still aren't ready for DSCSA Full story 2. Sandoz plans 2030 US launch for Ozempic generic Full story 3. 6 drugs now in shortage Full story 4. These hospitals are resolving physicians' IT…

Rite Aid exits bankruptcy | Wegovy + COVID-19: What to know | Dozens charged in pharmacy burglary ring | 2nd mpox shot approved | How health systems keep executive pay competitive

September 3, 2024 BHR Newsletter 1. Dozens charged in pharmacy burglary ring Full story 2. How health systems keep executive pay competitive Full story 3. FDA approves mpox vaccine requiring 15 'vigorous' jabs Full story 4. Learn best practices for managing…

Meijer opens pharmacy inside Corewell hospital | Flu shots: 2 key changes | 10 systems seeking pharmacy leaders | The scope of pharmacy deserts | CEO rebuilds system 'bleeding money'

August 29, 2024 BHR Newsletter 1. Lawmaker accuses CVS, Cigna, UnitedHealth execs of making false statement to Congress Full story 2. GLP-1s reduce cardiovascular mortality: Study Full story 3. Meijer opens pharmacy inside Corewell hospital Full story 4. Unlock the full…

ASHP slams J&J's 340B payment plan | 15 biggest specialty pharmacies | 6 weight loss drug updates | After Eli Lilly, Pfizer goes direct to consumer | Inside a system's split with UnitedHealth

August 28, 2024 BHR Newsletter 1. Pfizer goes direct to consumer Full story 2. Pharmacists slam J&J's plan to end upfront 340B discounts Full story 3. FDA clears 1st automated device for Type 2 diabetes Full story 4. Anticoagulants are…

FDA curbs COVID drug's EUA | Eli Lilly offers cheaper Zepbound | MetroHealth boosts refills by 45% | Drugmaker probed over trial misconduct claims

August 27, 2024 BHR Newsletter 1. Eli Lilly selling Zepbound vials at 50% discount: 4 notes Full story 2. MetroHealth upped patient refill retention by 45% — here's how Full story 3. FDA tightens EUA of preventive COVID drug Full story…